We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




INVITATION! Meet us at the Brazilian Society of Clinical Analysis 2023

By LabMedica International staff writers
Posted on 15 Jun 2023
We are pleased to announce Tianlong’s presence at the 48th Brazilian Society of Clinical Analysis, which presents a great opportunity for Tianlong to share our wealth of products and innovative technologies with the industry.

Brazilian Society of Clinical Analysis
DATES: 18 June – 21 June 2023
LOCATION: Costao do Santinho Resort, Florianopolis, Brazil
BOOTH: 69A+69B

Tianlong will be attending this event with our all-in-one molecular diagnosis system Panall 8000, our latest offering for PCR laboratory diagnostics.

Tianlong's newly launched Panall 8000 All-in-one Molecular Diagnosis System includes its self-developed full-automatic nucleic acid detection analysis system and a number of multi-pathogen nucleic acid detection kits. More...
Based on the principle of Magnetic Beads method and real-time PCR reaction, Panall 8000 can be matched with compatible reagents for sample nucleic acid extraction, in vitro nucleic acid amplification and analysis in molecular detection. It is a simple and secure molecular diagnosis system that integrates the functions of sample tube decapping/capping, sample loading, nucleic acid extraction, PCR setup, PCR detection and result analysis, and can detect up to 24 target genes in a single sample with one reagent, which can realize a true “sample in -result out” detection process and bring great convenience for professionals with only one-key operation.
Panall 8000 can be widely used in community hospital, hospital emergency, CDC and research institute. With the compatible reagents, Panall 8000 can run parallel detections, including pathogen detections in respiratory disease, sexual transmitted disease, gastroenteric diseases, etc., to provide an overall solution for early and accurate identification of pathogenic microorganisms.




New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Online QC Software
Acusera 24•7
POC Immunoassay Analyzer
Procise DX
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.